Head-to-head · free
United Microelectronics Corporation vs Exascale Labs
UMC vs XLAB — return on capital, cash generation, margins and balance sheet side by side.
UMC
3 / 3
measures where UMC leads
XLAB
0 / 3
measures where XLAB leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | UMC | XLAB · FY2026 |
|---|---|---|
| Revenue | — | $14.8M |
| Net income | — | (12.2M) |
| Revenue growth (yearly, multi-year) | — | — |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 8.4% | — |
| Return on equity | 11.0% | — |
| Gross margin | 29.0% | 15.8% |
| Operating margin | 18.4% | -43.4% |
| Net debt / EBITDA | -0.55x | 1.39x |
Figures are as reported by each company; latest fiscal year shown.
Where Exascale Labs's cash went (FY2026)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free